Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

James L. Rubenstein; Dan Combs; Jay Rosenberg; Arthur Levy; Michael McDermott; Lloyd Damon; Robert Ignoffo; Kenneth D Aldape; Arthur Shen; Dana Lee; Antonio Grillo-Lopez; Marc A. Shuman

doi:10.1182/BLOOD-2002-06-1636

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

James L. Rubenstein, Dan Combs, Jay Rosenberg, Arthur Levy, Michael McDermott, Lloyd Damon, Robert Ignoffo, Kenneth D Aldape, Arthur Shen, Dana Lee, Antonio Grillo-Lopez, Marc A. Shuman

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	101
DOIs	https://doi.org/10.1182/BLOOD-2002-06-1636
State	Published - Jan 15 2003

Disciplines

Pathology
Medicine and Health Sciences

Access to Document

10.1182/BLOOD-2002-06-1636License: Unspecified

Cite this

@article{e3896950b4b74331832cf70ce6d88b70,

title = "Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment",

author = "Rubenstein, \{James L.\} and Dan Combs and Jay Rosenberg and Arthur Levy and Michael McDermott and Lloyd Damon and Robert Ignoffo and Aldape, \{Kenneth D\} and Arthur Shen and Dana Lee and Antonio Grillo-Lopez and Shuman, \{Marc A.\}",

note = "Most lymphomas that involve the central nervous system are B-cell neoplasms that express the cell surface molecule CD20. After intravenous administration, ritux",

year = "2003",

month = jan,

day = "15",

doi = "10.1182/BLOOD-2002-06-1636",

language = "American English",

volume = "101",

journal = "Blood",

}

TY - JOUR

T1 - Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

AU - Rubenstein, James L.

AU - Combs, Dan

AU - Rosenberg, Jay

AU - Levy, Arthur

AU - McDermott, Michael

AU - Damon, Lloyd

AU - Ignoffo, Robert

AU - Aldape, Kenneth D

AU - Shen, Arthur

AU - Lee, Dana

AU - Grillo-Lopez, Antonio

AU - Shuman, Marc A.

N1 - Most lymphomas that involve the central nervous system are B-cell neoplasms that express the cell surface molecule CD20. After intravenous administration, ritux

PY - 2003/1/15

Y1 - 2003/1/15

UR - http://www.bloodjournal.org/content/101/2/466.long?sso-checked=true

U2 - 10.1182/BLOOD-2002-06-1636

DO - 10.1182/BLOOD-2002-06-1636

M3 - Article

VL - 101

JO - Blood

JF - Blood

ER -

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

Disciplines

Access to Document

Other files and links

Cite this